Cargando…
The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with mCSPC...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Urological Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004830/ https://www.ncbi.nlm.nih.gov/pubmed/32055749 http://dx.doi.org/10.4111/icu.2020.61.S1.S3 |